Literature DB >> 28983056

Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma.

Atanur Ersayin1, Aline Thomas2, Landry Seyve1, Nicole Thielens3, Mathieu Castellan1, Raphaël Marlu1, Benoît Polack1, Marie-Claire Dagher4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28983056      PMCID： PMC5709117          DOI： 10.3324/haematol.2017.174037

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Gla-domainless factor Xa: molecular bait to bypass a blocked tenase complex.

Authors:  Raphaël Marlu; Benoît Polack
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

Review 2.  Thrombin generation, a function test of the haemostatic-thrombotic system.

Authors:  H Coenraad Hemker; Raed Al Dieri; Erik De Smedt; Suzette Béguin
Journal:  Thromb Haemost       Date:  2006-11       Impact factor: 5.249

3.  Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Truman J Milling; John W Eikelboom; C Michael Gibson; John T Curnutte; Alex Gold; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Shelly Goodman; Janet Leeds; Brian L Wiens; Deborah M Siegal; Elena Zotova; Brandi Meeks; Juliet Nakamya; W Ting Lim; Mark Crowther
Journal:  N Engl J Med       Date:  2016-08-30       Impact factor: 91.245

Review 4.  2017 Clinical trials update: Innovations in hemophilia therapy.

Authors:  Jan Hartmann; Stacy E Croteau
Journal:  Am J Hematol       Date:  2016-10-03       Impact factor: 10.047

5.  The rediscovery and isolation of TFPI.

Authors:  G J Broze
Journal:  J Thromb Haemost       Date:  2003-08       Impact factor: 5.824

6.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.

Authors:  T J Girard; L A Warren; W F Novotny; K M Likert; S G Brown; J P Miletich; G J Broze
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

Review 7.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

8.  Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.

Authors:  Ida Hilden; Brian Lauritzen; Brit Binow Sørensen; Jes Thorn Clausen; Christina Jespersgaard; Berit Olsen Krogh; Andrew Neil Bowler; Jens Breinholt; Albrecht Gruhler; L Anders Svensson; Helle Heibroch Petersen; Lars Christian Petersen; Kristoffer W Balling; Lene Hansen; Mette Brunsgaard Hermit; Thomas Egebjerg; Birgitte Friederichsen; Mirella Ezban; Søren Erik Bjørn
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113

9.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

10.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157
View more
  3 in total

1.  Unexpected Dynamic Binding May Rescue the Binding Affinity of Rivaroxaban in a Mutant of Coagulation Factor X.

Authors:  Zhi-Li Zhang; Changming Chen; Si-Ying Qu; Qiulan Ding; Qin Xu
Journal:  Front Mol Biosci       Date:  2022-05-05

2.  Network-Based Integrated Analysis of Transcriptomic Studies in Dissecting Gene Signatures for LPS-Induced Acute Lung Injury.

Authors:  Fang Cao; Chunyan Wang; Danling Long; Yujuan Deng; Kaimin Mao; Hua Zhong
Journal:  Inflammation       Date:  2021-08-30       Impact factor: 4.092

3.  In vitro reversal of direct factor Xa inhibitors: Direct comparison of andexanet alfa and prothrombin complex concentrates Cofact and Beriplex/Kcentra.

Authors:  Herm Jan M Brinkman; Marleen Zuurveld; Joost C M Meijers
Journal:  Res Pract Thromb Haemost       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.